This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. This article focuses on the Department of Public Health (IDPH) portion of the report, which touts this year’s accomplishments as hiring needed staff and hosting Medical Cannabis Advisory Board (MCAB) meetings.
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. This article focuses on the Department of Agriculture (IDOA), which is the lead regulator for a broad swath of the cannabis industry in Illinois and consists of three bureaus.
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. This article focuses on the Department of Financial & Professional Regulation (IDFPR) portion of the report, which touts FY2024 as “a year of explosive growth in the cannabis industry” in Illinois.
information comes available such as supplier pricing, stock changes, running costs, accounting. The ERP operates as a system, collecting data in real time and connecting it all together for your. Since the ERP is equipped with all of the company’s information, the access to data is controlled. Access Control.
CBE have published the following article. Read the full article at. From data-related class action concerns to security disclosures and labeling issues, cannabis companies may see themselves facing class action filings. Here are a selection of the highlights. Increasing Cannabis Class Action Risks.
A combination of factors has led the FDA to provide consumers with this information. For more information about Delta-8 THC: CDC HEALTH ALERT NETWORK (HAN). Findings based on NPDS data do not necessarily reflect the opinions of AAPCC. Keep these products out of reach of children and pets. exposures to any substance(s).
Introducing the centre’s annual report on 9 June, 1 Goosdeel explained that the UK’s departure from the European Union was depriving his team of valuable British expertise and data for the centre, which provides policy makers with scientific, evidence based, and comparable information of the evolving drug problem.
AP sought information about testing of spiked CBD from federal law enforcement as well as crime labs or other law enforcement authorities in all 50 states. AP then used that information, as well as postings from online discussion boards, to purchase vape products that could be spiked, and lab tested those samples. —
Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.
Editor’s Note: This following blog is an excerpt from an article that appeared in the March/April 2019 issue of Terpenes & Testing Magazine. View the full article. . Whole Genome Data. When it comes to sequencing your cultivar’s genetics for IP purposes, the more data the better. Sequencing Methods.
Look no further than the 7th paragraph of the CNN article, where the lead author of the study is quoted as saying that the study “did not research how cannabis affects heart health.”. of non-users who experienced heart attacks was small enough to be “within the margin of error for nearly any survey or polling data.”
Greg Kaufman of Eversheds Sutherland outlines the key provisions and urges lawmakers to consider data collected at the state level to get it right. This summer three U.S. On July 14, 2021, U.S. Senators Chuck Schumer (D-N.Y.), Cory Booker (D-N.J.) and Ron Wyden (D-Ore.)
Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.
The plan follows two reports to Congress last year (which the Perkins Coie Cannabis Industry Group has previously written about here and here ) on the safety and labeling of products containing cannabidiol (CBD) and a public statement from outgoing FDA leadership in early 2021 seeking better data for a better understanding of CBD safety.
When Oregon voters passed Measure 109 in 2020, to create a legal framework for access to psilocybin services, the ballot initiative explicitly prevented the government from collecting that sensitive personal information without consent. […]
Drilling down into the cannabis trademark landscape in 2018 uncovered a heavy focus on goods in Classes 34 (smokers’ articles) and 5 (medicines/pharmaceuticals), as well as Nice classes relating to food and drink products. Smokers’ articles. Smokers’ articles. TS Brandco Inc. Dutch Passion Holding BV. Edible oils.
THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.
The findings are based on insights generated daily from the Similarweb Olympics Digital Tracker , a one-stop-shop for data coverage of this year’s Summer Olympic Games including traffic leaders, industry rankings, audience search interest and more. Similarweb shall not be held responsible for the accuracy of or any omissions from its data.
The second announcement (see previous article for first announcement ) focused on the implementation of a paperless registration system for cannabis businesses. Historically, these processes have been paper-based, creating inefficiencies in data management and submission. For more information on News Joint Bar Service, visit here.
This article was originally published on Analytical Cannabis and appears here with permission. . We also lack information about the extent to which the PD community is informed about medicinal cannabis and whether they have tried cannabis and, if so, with what result.”.
The team of researchers analyzed data from nearly 20,000 people over a four-year period and found that cannabis use among cancer patients peaked at 9%. ” The researchers from VCU make use of data collected from the Population Assessment of Tobacco and Health (PATH), which tracked tobacco AND cannabis smoking behaviors.
There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.
David focuses on complex business and commercial litigation in state and federal courts involving data security and privacy, product liability and business disputes. cookies), medical information, biometric information, and geolocation data, among other categories.
That’s what the data shows from around the country.’. Building on a prior study that analyzed YRBS data from 1993-2017, this updated effort offers an expanded view on the subject by adding in results from 2018 and 2019 as well. Someone should inform Gov. View Zack Ruskin’s articles. View original article.
The latest article in Healthcare Business Today cites the company’s Multiomics Advanced Technology™ (MAT) as the driver for more accurate predictions about disease states and individual responses to diseases and treatments that will make medicine truly personalized. www.GATCHealth.com. Disclaimer.
The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.
Giving new information. . Qualitative and Quantitative Research: Qualitative research aims to use the social sciences to “collect, compare and interpret information”, while quantitative research aims to use “mathematical, statistical and computer-aided tools” to collect and measure the data. .
About a year ago, Adam from Twenty20 Mendocino penned an article about his thoughts on how copyrights and trademarks for strain names will, once cannabis is no longer a Schedule 1 Drug, fall under the category of public domain. This information includes the strain’s onset, intensity, duration, and any side effects.
We don’t usually report these pieces but as it is in the FT the information is probably worth the once over. The world’s largest cannabis ETF, the US-listed ETFMG Alternative Harvest, which has $673m of assets according to data compiler ETFGI, lost 28.5 Read the full article at [link]. per cent last year.
The Chief Operating Officer of BioTrackTHC, Moe Afaneh, gave a high-level overview of the company’s seed-to-sale software for state-level data collection. Any individual who will be inputting data into the track and trace system under either the medical or adult use program must be registered with OMP and will need to receive training.
In this article, we’ll delve into the newest research findings and explore how medicinal cannabis could revolutionize cancer pain management and reduce reliance on opioids and other medications. Note: The content on this page is for informational purposes only and is not intended to be professional medical advice.
The feds are looking for information on how cannabis and/or Kratom might treat pain. The AHRQ is hoping to gather information on four specific questions in particular. The AHRQ told media, “Some data suggest that cannabinoids may have analgesic properties, though research in this area is mixed. A Statement from the AHRQ.
FDA has wrongly mischaracterized these products as the same article as a prescription drug and has ignored, dismissed, and downplayed ample evidence that these full-spectrum hemp products can be marketed in a manner that is reasonably expected to be safe. In June 2019, CRN submitted comments to FDA with scientific data and information on CBD.
Featured in the journal Cannabis and Cannabinoid Research , the guidelines were compiled after researchers perused scientific databases for peer-reviewed English articles on cannabis and pain. The team peered into the findings of numerous articles published between 2001 and 2019.
Based on the data from the study, the breakdown of why U.S. When you put those findings together with data from High Yield Insights’ recent report , The CBD Consumer Experience (parts I and II), it’s much easier to understand what consumers want from CBD brands based on the 4 Ps of marketing: product, price, place, and promotion.
WORCESTER —On the eve of Wednesday, September 1, the Cannabis Control Commission (Commission)’s fourth birthday, adult-use Marijuana Establishments in Massachusetts surpassed $2 billion in gross sales , according to information reported in the state’s mandatory seed-to-sale tracking system, the agency announced today.
But there is a general lack of understanding for the new industry and limited data on performance that could be contributing factors. Big data and analytics will play a critical role in helping to contain and manage the risks within the industry. There could many reasons for this. It starts with connecting the dots.
The data from numerous research studies speaks for itself: Sales increase by 29% for businesses that use CRM. For leads in the middle of the funnel, your goal is to engage them with useful, interesting information and messages that keep your brand top-of-mind and build trust in your brand. . Source: Salesforce). Source: Cloudswave).
According to data from Bureau of Justice Statistics , 80 percent in federal prison and 60 percent of people in state prison, who were incarcerated because of a drug offense, are Black or Latino. . Results from data released by the MRA show that in 2020, only 3.8 Results from data released by the MRA show that in 2020, only 3.8
Bottom-line, it’s extremely difficult to stay competitive in any industry today without a customer relationship management (CRM) system in place, and the data proves it. You can use that information to identify your best customer profiles and more effectively target matching leads through your marketing initiatives.
As set out above, the Company understands that Brown Shipley is unable to exercise its security over the Pledged Shares until 1 July 2022 and has been informed that KCP are in discussions with Brown Shipley about removing the Pledged Shares from the Charge and will update the market accordingly. Aggregated information. . 198,466,493.
Cannabiz Media recently spoke with Tony Repanich, President and Chief Operating Officer at Shield Compliance, to learn more about how he and his team use the Cannabiz Media License Database to support their business development, data intelligence, and license verification processes. View original article.
According to an article in the Detroit Metro Times, Michigan’s cannabis market is on track to hit the 1 billion dollar milestone California achieved back in 2017. Statistical data published by Headset Insights Pulse revealed that Michigan’s medical and recreational cannabis markets in 2020 brought in 313.7 million and 281.2
This article from the Portland Press Herald includes information from a study by Dr. Sulak in 2016 that showed 85% of 525 of his practice’s patients reported a decrease in or cessation of opioid use when using medical cannabis. Dr. Sulak’s Cannabis and Opioid Guide. How To Use Cannabis to Reduce & Replace Opioids.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content